A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

Inclusion Criteria:

The following is the inclusion criteria for pretest interviews and final online survey.

Participants:

• Must be 18 years of age or older
• Must be a US resident.
• Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

Exclusion Criteria:

• Not applicable

Other protocol-defined inclusion/exclusion criteria apply